Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

10 February, 2026 | Tuesday

Overcoming Throughput, Standardization, And Analysis Challenges for Human Midbrain Organoids

Organoids also hold advantages over animal models, which inherently possess species-dependent differences and can be logistically and ethically challenging...

April 17, 2023 | Monday | News

Why Compliance Matters and Why Patients Should Care

Clinical trials recruited hundreds of thousands of patients, while families in lockdown waited, hoping for regulatory approval of a COVID-19 vaccine that w...

April 09, 2023 | Sunday | Opinion

Three Principles of Responsibility for Artificial Intelligence (AI) in Healthcare

Artificial Intelligence in Healthcare In healthcare, AI has the potential to drive scientific breakthroughs, aid in diagnosis, treatment, and management o...

April 09, 2023 | Sunday | Analysis

1
2
3

Partner Content

BioPharma BreakThrough's

Affidea Acquires Majority Stake in LabPoint to Build Integrated Precision Diagnostics Platform in Switzerland
16 January, 2026
Enginzyme and AGC Present Scalable Manufacturing Process for Key mRNA Ingredient m¹ΨTP
13 January, 2026
Incyte Announces FDA Breakthrough Therapy Designation for INCA033989 for Essential Thrombocythemia with Type 1 CALR Mutation
08 December, 2025
AstraZeneca Showcases Broad Advances in Blood Cancer and Rare Disease Care With 65 Presentations at ASH 2025
05 December, 2025
MUVON Therapeutics Reports Positive Topline Results From Phase 2 SUISSE-MPC2 Trial of MPC-Based Therapy in Female Stress Urinary Incontinence
04 December, 2025
VNA-318 Demonstrates Strong Target Engagement and Safety in First-in-Human Trial
03 December, 2025

Editor Picks

China’s NMPA Approves Almirall’s Seysara® for Moderate-to-Severe Acne
30 January, 2026
Elevar Submits NDA for Lirafugratinib as Second-Line FGFR2-Driven Cholangiocarcinoma Therapy
30 January, 2026
Imviva Biotech’s CTD402 Granted FDA Orphan Drug Designation for Relapsed/Refractory T-ALL/LBL
29 January, 2026

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2026 Biopharma Boardroom. All Rights Reserved.